| Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. | glioma, |
| Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. | sarcoma, |
| Coexpression of hepatocyte growth factor and its receptor (c-met oncogene) in HGL4 glioblastoma cells. | glioblastoma, |
| Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. | liver, |
| Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. | HNSC, |
| Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. | liver, |
| Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. | kidney, |
| [The overexpression of c-met oncogene correlation with gastric mucosal lesion]. | gastric, |
| The receptor encoded by the human C-MET oncogene is expressed in testicular tissue and on human spermatozoa. | testicular, |
| C-met proto-oncogene expression in benign and malignant human renal tissues. | kidney, |
| Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. | colorectal,liver, |
| Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. | kidney, |
| Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours. | kidney, |
| Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma. | sarcoma, |
| Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth. | kidney, |
| Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. | None |
| Induction of c-met proto-oncogene expression at the metastatic site. | None |
| Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3 -kinase-dependent autocrine loop involving hyaluronic acid and CD44. | None |
| Signature-based analysis of MET proto-oncogene mutations using DHPLC. | None |
| [Paracrine regulation of the c-met proto-oncogene transcript by stromal cells in BMP tumor cells with different metastatic potential]. | None |